Is IOVA stock safe? | Glauxie AI

Q: Is IOVA stock safe?

Iovance Biotherapeutics, Inc. (IOVA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Frederick G. Vogt. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to... Employees: 975.

Q: What are the risks of investing in IOVA?

Identify key risks of investing in IOVA — debt, competition, volatility, and sector headwinds.

Q: Is IOVA a good long-term investment?

Evaluate IOVA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does IOVA have?

Review IOVA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is IOVA stock safe?

🦉

Iovance Biotherapeutics, Inc. (IOVA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOFrederick G. Vogt

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead...

Key Executives

Name	Title
Brian Shew	Senior Vice President & Head of Digital and Information Technology
Corleen Roche	Chief Financial Officer
Daniel G. Kirby	Chief Commercial Officer
Elma S. Hawkins	Advisor to the Board
Frederick G. Vogt	Interim Chief Executive Officer, President, General Counsel, Corporate Secretary & Director
Friedrich Graf Finckenstein	Chief Medical Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

IOVA Profile Financials

What are the risks of investing in IOVA? Is IOVA a good long-term investment? How much debt does IOVA have?